FONT SIZE   S | M | L
clear
Tuesday, 23 August 2016
Clarifying PVRL's pathogenesis, its diagnosis and its optimal treatment.
Share
clear

Excerpt from a recent Abstract...

Purpose of review: Primary vitreoretinal lymphoma (PVRL) is a subset of primary central nervous system lymphoma in which disease primarily affects the uvea, retina, vitreous and optic nerve. This review discusses recent efforts to clarify the disease's pathogenesis, its diagnosis and its optimal treatment.

Recent findings: PVRL typically masquerades as a chronic intermediate uveitis in older individuals. Unambiguous diagnosis requires cytologic demonstration of malignant cells in a vitreous or chorioretinal specimen. However, cytokine analysis demonstrating increased interleukin 10 (IL 10) levels or increased IL-10:IL-6 ratio in the aqueous or vitreous, flow cytometry demonstrating a monoclonal cell population, molecular analysis demonstrating gene rearrangements or translocations or combinations of several techniques can be used effectively to aid in diagnosis. Treatment is aimed at eradication of disease within the eyes and prevention of central nervous system (CNS) lymphoma. Whether this should be done with local therapy alone (globe irradiation or intravitreal chemotherapy such as methotrexate or rituximab), or with systemic chemotherapy remains a source of debate. Even with high-dose systemic chemotherapy, CNS disease is prone to recurrence and has a poor prognosis.

Summary: New techniques and innovative treatment strategies may streamline time to definitive diagnosis and may lead to prolonged survival with better vision in patients with PVRL.

Find David Reichstein's full article at http://journals.lww.com/co-ophthalmology

clear
Posted on 08/23/2016 2:10 PM by Dena Beck
Comments
No comments yet.
sun mon tue wed thu fri sat
   1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31   

"Had a sudden retinal tear late on Dec 23. Dr Recchia saw me on Christmas Eve and saved my sight with surgery. Super staff, very happy!"

Eric
via Facebook